Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy
Open Access
- 8 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 21 (1), 1-10
- https://doi.org/10.1186/s12879-021-06336-9
Abstract
Hepatitis C virus (HCV) infection represents a global health issue with severe implications on morbidity and mortality. This study aimed to evaluate the impact of HCV infection on all-cause, liver-related, and non-liver-related mortality in a population living in an area with a high prevalence of HCV infection before the advent of Direct-Acting Antiviral (DAA) therapies, and to identify factors associated with cause-specific mortality among HCV-infected individuals. We conducted a cohort study on 4492 individuals enrolled between 2003 and 2006 in a population-based seroprevalence survey on viral hepatitis infections in the province of Naples, southern Italy. Study participants provided serum for antibodies to HCV (anti-HCV) and HCV RNA testing. Information on vital status to December 2017 and cause of death were retrieved through record-linkage with the mortality database. Hazard ratios (HRs) for cause-specific mortality and 95% confidence intervals (CIs) were estimated using Fine-Grey regression models. Out of 626 deceased people, 20 (3.2%) died from non-natural causes, 56 (8.9%) from liver-related conditions, 550 (87.9%) from non-liver-related causes. Anti-HCV positive people were at higher risk of death from all causes (HR = 1.38, 95% CI: 1.12–1.70) and liver-related causes (HR = 5.90, 95% CI: 3.00–11.59) than anti-HCV negative ones. Individuals with chronic HCV infection reported an elevated risk of death due to liver-related conditions (HR = 6.61, 95% CI: 3.29–13.27) and to any cause (HR = 1.51, 95% CI: 1.18–1.94). The death risk of anti-HCV seropositive people with negative HCV RNA was similar to that of anti-HCV seronegative ones. Among anti-HCV positive people, liver-related mortality was associated with a high FIB-4 index score (HR = 39.96, 95% CI: 4.73–337.54). These findings show the detrimental impact of HCV infection on all-cause mortality and, particularly, liver-related mortality. This effect emerged among individuals with chronic infection while those with cleared infection had the same risk of uninfected ones. These results underline the need to identify through screening all people with chronic HCV infection notably in areas with a high prevalence of HCV infection, and promptly provide them with DAAs treatment to achieve progressive HCV elimination and reduce HCV-related mortality.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro, Milan, Italy (Grant No. 8942)
- International Agency for Cancer Research, Lyon, France (no grant n. available)
- Ricerca Corrente Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy (no grant n. available)
- IRCCS Istituto Nazionale per le Malattie Infettive L. Spallanzani, Rome, Italy (no grant n. available)
This publication has 49 references indexed in Scilit:
- A systematic review of hepatitis C virus epidemiology in Europe, Canada and IsraelLiver International, 2011
- Increased Mortality Among Persons Infected With Hepatitis C VirusClinical Gastroenterology and Hepatology, 2011
- Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residentsJournal of Viral Hepatitis, 2010
- Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancerEuropean Journal of Cancer, 2008
- Increased All-Cause, Liver, and Cardiac Mortality among Hepatitis C Virus-seropositive Blood DonorsAmerican Journal of Epidemiology, 2008
- FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotestJournal of Hepatology, 2007
- Hepatitis Viruses, Alcohol, and Tobacco in the Etiology of Hepatocellular Carcinoma in ItalyCancer Epidemiology, Biomarkers & Prevention, 2006
- Methodology Used for “Software for Automated Linkage in Italy” (SALI)Journal of Biomedical Informatics, 2001
- Hepatitis C virus (HCV) infection and liver-related mortality: a population-based cohort study in southern ItalyInternational Journal of Epidemiology, 2000
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999